Neuropsychophysical optimization by REAC technology in the treatment of: sense of stress and confusion. Psychometric evaluation in a randomized, single blind, sham-controlled naturalistic study
Vania Fontani1, Lucia Aravagli1, Matteo Lotti Margotti2, Alessandro Castagna1, Piero Mannu1, Salvatore Rinaldi1
1Department of Neuro Psycho Physio Pathology, 2Department of Information Technology and Statistical Analysis, Rinaldi Fontani Institute, Florence, Italy
Purpose: The aim of this study is to investigate the effects of neuropsychophysical optimization (NPPO) protocol treatment by radioelectric asymmetric conveyer (REAC) technology in the management of sense of stress and confusion (SSC); an analysis of a single cluster of the psychological stress measure (PSM) test.
Patients and methods: The PSM, a self-administered questionnaire, was used to measure psychological stress and SSC for a group of 888 subjects. Data were collected immediately prior to and following the 4-week REAC-NPPO treatment cycle.
Results: This study demonstrates a significant reduction in scores measuring subjective perceptions of stress for subjects treated with one cycle of REAC-NPPO. At the end-point of the study, the number of treated subjects reporting symptoms of stress-related SSC on the PSM test was significantly reduced, whereas there was no difference in sham-treated subjects.
Conclusion: One cycle of REAC-NPPO appears to reduce subjective perceptions of SSC measured by the PSM.
Trial registration: This trial has been registered in the Australian New Zealand Clinical Trials Registry as ACTRN12607000497404.
Keywords: stress disorders, adaptation disorders, REAC, NPPO
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.